UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000042656
Receipt No. R000048662
Scientific Title Effect on ARNI on renal function and body fluid volume
Date of disclosure of the study information 2020/12/05
Last modified on 2022/08/15 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect on ARNI on renal function and body fluid volume
Acronym Effect on ARNI on renal function and body fluid volume
Scientific Title Effect on ARNI on renal function and body fluid volume
Scientific Title:Acronym Effect on ARNI on renal function and body fluid volume
Region
Japan

Condition
Condition Congestive heart failure
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Effect on ARNI on renal function and body fluid volume
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Urine volume from day 0 to day 5.
Key secondary outcomes Transition of creatinine, eGFR, body weight, NAG and NT-proBNP from day 0 to day 5.
The incidence of death and rehospitalization for heart failure within 60 days.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1)Patients 20 years of age or older were eligible for inclusion in trial if they had left ventricular ejection fraction of 40% or less and had primary diagnosis of congestive heart failure
(2)Stable cardiohemodynamics(sBP >= 90 mmHg)
(3)Not in use inotrope
Key exclusion criteria (1)contraindication in packge insert
(2)Cardiogenic shock
(3)ACS
(4)Pregnancy
(5)A patient who started clinical trials
(6)A patient who couldn't attend a hospital
(7)A patient improper to this clinical trial according to the decision of a principal investigator
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Yu
Middle name
Last name Horiuchi
Organization Mitsui Memorial Hospital
Division name Division of Cardiology
Zip code 101-8643
Address Kanda-Izumicho 1, Chiyoda-ku, Tokyo
TEL 03-3862-9111
Email yooouyou@gmail.com

Public contact
Name of contact person
1st name Naoto
Middle name
Last name Setoguchi
Organization Mitsui Memorial Hospital
Division name Division of Cardiology
Zip code 101-8643
Address Kanda-Izumicho 1, Chiyoda-ku, Tokyo
TEL 03-3862-9111
Homepage URL
Email naoto.stgc@gmail.com

Sponsor
Institute Mitsui Memorial hospital
Institute
Department

Funding Source
Organization Mitsui Memorial Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Mitsui Memorial Hospital
Address Kanda-Izumicho 1, Chiyoda-ku, Tokyo
Tel 03-3862-9111
Email c-uno@mitsuihosp.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 12 Month 05 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Main results already published
Date of protocol fixation
2020 Year 10 Month 29 Day
Date of IRB
2020 Year 11 Month 27 Day
Anticipated trial start date
2021 Year 01 Month 01 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
2022 Year 03 Month 31 Day
Date trial data considered complete
2022 Year 03 Month 31 Day
Date analysis concluded
2022 Year 08 Month 01 Day

Other
Other related information prospective observational study

Management information
Registered date
2020 Year 12 Month 04 Day
Last modified on
2022 Year 08 Month 15 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048662